Journal Information
Vol. 27. Issue. S5.October 2007
Pages 1-67
Full text access
Is tolvaptan (a vasopressin V2 receptor antagonist) effective in the management of isovolumic and hypervolaemic hypernatremia?
¿El tolvaptán, un antagonista de los receptores de la vasopresina V2, ¿es un tratamiento eficaz para la hiponatremia euvolémica e hipervolémica?
Visits
3335
F. Ortiz
This item has received
Idiomas
Nefrología (English Edition)
Article options
Tools